Wadih Baajour

Feb 12, 2024 | onlinelibrary.wiley.com | Samuel W. Terman |Laura E. Kirkpatrick |Lisa Akiyama |Wadih Baajour

This review discusses the latest drugs and devices in the epilepsy diagnostics and therapeutics pipeline. Many antiseizure medications plus other genetic and nongenetic therapeutics are currently under development, including many that are first-in-class. Seizure tracking, detection, and stimulation devices all continue to make advances as devices enter the pipeline. 1 INTRODUCTION The need remains for innovation in epilepsy diagnostics and treatments.